Lido Advisors, LLC Bio Xcel Therapeutics, Inc. Transaction History

Lido Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$20.12 - $35.09 $334,857 - $584,002	-16,643 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$23.84 - $32.03 $189,384 - $254,446	7,944 Added 91.32%	16,643 $505,000
Q2 2021 Aug 12, 2021	BUY	$29.06 - $38.83 $97,641 - $130,468	3,360 Added 62.93%	8,699 $253,000
Q1 2021 May 13, 2021	SELL	$39.04 - $64.6 $74,371 - $123,062	-1,905 Reduced 26.3%	5,339 $230,000
Q4 2020 Feb 08, 2021	BUY	$42.46 - $56.58 $307,580 - $409,865	7,244 New	7,244 $334,000

3.14M

22.2K

40.2K

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $14.3M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

Get notified when there are updates to the investment portfolio of Lido Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Lido Advisors, LLC with notifications on news.